Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
暂无分享,去创建一个
Jacques P. Brown | L. Hofbauer | J. Wark | C. Roux | A. Fahrleitner-Pammer | S. Minisola | J. Brown | N. Papaioannou | S. Siddhanti | P. Ho | M. Zillikens | R. Wagman | F. Hawkins | M. Stone | I. Ferreira | M. Micaelo